Disease activity, damage and survival in Mexican patients with acute severe systemic lupus erythematosus

Lupus

Volumn 16, Issue 12, 2007, Pages 997-1000

  Zonana Nacach, Abraham ^a,c   Yanez P ^b   Jimenez Balderas F J ^b   Camargo Coronel, A ^b  

^a Hospital General Regional No 20 del IMSS   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c NONE   (United States)

Author keywords

Acute severe SLE; Damage; Disease activity; Survival

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONFIDENCE INTERVAL; DISEASE ACTIVITY; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LOGISTIC REGRESSION ANALYSIS; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; VASCULITIS;

ACUTE DISEASE; ADOLESCENT; ADULT; COHORT STUDIES; HOSPITALIZATION; HUMANS; INFECTION; KAPLAN-MEIERS ESTIMATE; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MEXICO; ODDS RATIO; SEVERITY OF ILLNESS INDEX; THROMBOCYTOPENIA;

EID: 37849014580     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203307083175     Document Type: Article

References (16)

1. Bernatzky S, Boivin JF, Joseph L et al. Mortality in systemic lupus erythematosus. Arthritis Rheum 2006; 54: 2550-2557.
2. Petri M, Genovese M. Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: a prospective study of the Hopkins lupus cohort. J Rheumatol 1992; 19: 1559-1565.
3. Cervera R, Khamashta MA, Font J et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine 2003; 82: 299-308.
4. Petri M, Genovese M, Engle E, Hochberg M. Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study. Arthritis Rheum 1991; 34: 937-944.
5. Zonana-Nacach A, Salas M, Sánchez ML, Camargo-Coronel A, Bravo-Gatica C, Mintz GJ. Measurement of clinical activity of systemic lupus erythematosus and laboratory abnormalities: twelve-months prospective study. Rheumatol 1995; 22: 45-49.
6. Barr SG, Zonana-Nacach A, Madger LS, Petri M. Patterns of disease activity in systemic lupus erythematosus. Arthritis Rheum 1999; 42: 2682-2688.
7. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
8. Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1107-1118.
9. Bombardier C, Gladman D, Urowitz M et al. Derivation of SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992; 19: 53-59.
10. Gladman DD, Goldsmith CH, Urowitz MB et al. The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. J Rheumatol 2000; 27: 373-376.
11. Edwards CJ, Lian TY, Badsha H, Teh CL, Arden N, Chng HH. Hospitalization of individuals with systemic lupus erythematosus:characteristics and predictors of outcome. Lupus 2003; 12: 672-676.
12. Krishnan E. Hospitalization and mortality of patients with systemic lupus erythematosus. J Rheumatol 2006; 33: 1770-1774.
13. Zonana-Nacach A, Camargo-Coronel A, Yañez P et al. Measurement of damage in 210 Mexican patients with systemic lupus erythematosus: relationship with disease duration. Lupus 1998; 7: 119-123.
14. Zonana-Nacach A, Barr SG, Magder LS, Petri M. Damage in systemic lupus erythematosus and its association with corticosteroids. Arthritis Rheum 2000; 43: 1801-1808.
15. Cook RJ, Gladman DD, Pericak D, Urowitz MB. Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity. J Rheumatol 2000; 27: 1892-1895.
16. Rahman P, Gladman DD, Urowitz MB, Hallett D, Tam LS. Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus. Lupus 2001; 10: 93-96.